BIO-TECHNE Corp (TECH) stock
TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 12, 2026Score 11/3040% above fair value
$72.80−0.04 (-0.05%)
Close on Nov 13, 2026Market cap $11.43BP/E 66.8Yield 0.44%
Bio-Techne total assets
Total assets on the balance sheet at the end of each period.
Bio-Techne's total assets was $2.64B at Sep 30, 2026. For fiscal 2026 it was $2.59B, up 1.1% from the year before. Over ten years it grew 8.6% a year on average. The highest annual figure on record is $2.70B in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $2.59B | +1.1% |
| FY2025 | Jun 30, 2025 | $2.56B | -5.4% |
| FY2024 | Jun 30, 2024 | $2.70B | +2.5% |
| FY2023 | Jun 30, 2023 | $2.64B | +15.0% |
| FY2022 | Jun 30, 2022 | $2.29B | +1.4% |
| FY2021 | Jun 30, 2021 | $2.26B | +11.6% |
| FY2020 | Jun 30, 2020 | $2.03B | +7.6% |
| FY2019 | Jun 30, 2019 | $1.88B | +18.3% |
| FY2018 | Jun 30, 2018 | $1.59B | +2.2% |
| FY2017 | Jun 30, 2017 | $1.56B | +37.9% |
| FY2016 | Jun 30, 2016 | $1.13B | +6.2% |
| FY2015 | Jun 30, 2015 | $1.06B | +23.3% |
| FY2014 | Jun 30, 2014 | $862.49M | +10.8% |
| FY2013 | Jun 30, 2013 | $778.10M | +8.2% |
| FY2012 | Jun 30, 2012 | $719.32M | +16.5% |
| FY2011 | Jun 30, 2011 | $617.67M | +19.1% |
| FY2010 | Jun 30, 2010 | $518.82M | +9.9% |
| FY2009 | Jun 30, 2009 | $472.01M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $2.64B | +4.4% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $2.59B | +1.1% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $2.55B | -3.5% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $2.52B | -5.5% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $2.53B | -7.7% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $2.56B | -5.4% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $2.64B | -2.8% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $2.67B | -2.2% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $2.74B | -0.7% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $2.70B | +2.5% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $2.72B | +4.7% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $2.73B | +15.5% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $2.76B | +17.2% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $2.64B | +15.0% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $2.60B | +13.0% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $2.36B | +2.5% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $2.35B | +3.5% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $2.29B | +1.4% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $2.30B | +10.3% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $2.30B | +11.5% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $2.27B | +10.6% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $2.26B | +11.6% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $2.08B | +4.3% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $2.07B | +3.5% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $2.05B | +6.7% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $2.03B | +7.6% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $2.00B | +6.8% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $2.00B | +8.3% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $1.93B | +2.8% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $1.88B | +18.3% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $1.87B | +15.8% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $1.84B | +18.6% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $1.87B | +22.6% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $1.59B | +2.2% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $1.62B | +5.5% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $1.56B | +2.3% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $1.53B | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $1.56B | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $1.53B | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $1.52B | – |
See a number that looks wrong?